Related Experiment Video
Updated: Jan 2, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare
Jyothsna Giri1, Ann M Moyer2, Suzette J Bielinski3
1Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
Pharmacogenomics (PGx) offers significant precision medicine potential but faces implementation challenges. Addressing these requires ongoing research, standardized testing, and education for widespread clinical adoption.
Area of Science:
- Pharmacogenomics (PGx) research and clinical application.
- Precision medicine and healthcare integration.
Background:
- Pharmacogenomics (PGx) is a key area of precision medicine with high potential for clinical impact.
- Advances in PGx knowledge and decreasing test costs increase interest in its translation to healthcare.
- Implementing PGx into clinical workflows is complex and requires multidisciplinary collaboration.
Purpose of the Study:
- To review and categorize challenges in clinical pharmacogenomics (PGx) implementation.
- To identify gaps and propose solutions for integrating PGx into healthcare.
- To highlight the need for ongoing research, standardization, and education.
Main Methods:
- Review and categorization of existing pharmacogenomics (PGx) implementation models and challenges.
- Exploration of issues related to electronic health records, clinical decision support, and testing standardization.
- Evaluation of educational needs and lessons learned from previous implementation efforts.
Main Results:
- Clinical pharmacogenomics (PGx) implementation faces hurdles in workflow integration, electronic health records, and decision support.
- Standardization of PGx testing and reporting is critically needed across laboratories.
- Effective translation requires addressing knowledge complexity and developing educational strategies for healthcare teams.
Conclusions:
- Despite challenges, pharmacogenomics (PGx) holds promise for precision medicine.
- Continued basic and clinical research is essential for evidence-based advancements.
- Multidisciplinary efforts are crucial for translating pharmacogenomics (PGx) into routine clinical practice.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Related Concept Videos
Biopharmaceutics and Pharmacokinetics: Overview
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Analysis of Population Pharmacokinetic Data
Factors Affecting Drug Response: Overview